Navigation Links
Breckenridge Announces Dismissal of Various Lawsuits Against Macoven Pharmaceuticals in Return for Macoven's Discontinuance of Certain Products
Date:7/9/2013

BOCA RATON, Fla., July 9, 2013 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that Nestle Health Science-Pamlab and Merck & Cie have dismissed their patent litigation against Macoven Pharmaceuticals, LLC., and Breckenridge has dismissed its Lanham Act litigation against Macoven.   In return, Macoven has agreed to immediately and permanently cease all manufacturing, use, sale, offers for sale, importation, distribution, advertising, promotion, marketing its generic, unlicensed L-methylfolate calcium salt products.   Macoven's discontinued products include:  VitaCirc-B, Alz-NAC, L Methylfolate PNV DHA, L-Methylfolate Calcium 7.5, and L-Methylfolate Calcium 15.

Merck & Cie is the exclusive manufacturer and supplier of the ingredient Metafolin® (L-methylfolate calcium), and is the owner of multiple U.S. patents covering Metafolin®.   Nestle Health Science-Pamlab markets the only branded medical foods in the United States which contain Metafolin®.  Since 2007, Breckenridge has served as the exclusive authorized-generic supplier of Nestlé Health Science-Pamlab brands, from folic acid products to Metafolin®-containing medical foods.  

About Breckenridge Pharmaceutical, Inc.
Breckenridge is a privately-held pharmaceutical marketing, research and development company founded in 1983 that markets a broad range of generic prescription products and Medical Foods in many therapeutic categories. The Breckenridge label is recognized by Wholesalers, Distributors, Chains, and Managed Care Accounts, as well as Retail Pharmacies nationwide. The company markets over 60 products in a variety of dosage forms including: Tablets, Capsules, Soft Gel Capsules, Liquids, and Powders.

 


'/>"/>
SOURCE Breckenridge Pharmaceutical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Breckenridge Pharmaceutical signs Letter of Intent with Welding GmbH & Co & SK Chemicals
2. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
3. Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets
4. BiOptix announces low cost Surface Plasmon Resonance Services for Colorado-based researchers
5. Depomed Announces Appointment of Louis J. Lavigne, Jr. to Board of Directors
6. Blue Sky BioServices Expands its Executive Team - Announces Appointment of Ted Marple as President and CEO
7. Concord Medical Announces Launch of Mobile Health Application
8. Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261 (Intranasal Midazolam) For Rescue Treatment Of Seizure Clusters In Epilepsy
9. Valeant Pharmaceuticals Announces Closing of Public Offering of Common Shares
10. Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod
11. Simcere Pharmaceutical Group Announces Sale of Equity Interest in Boda
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and ... women in the world, and the most handsome men, look naturally attractive. Plastic ...
Breaking Medicine News(10 mins):